Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Strategies for monetization of patent portfolios in chemical fields

MARCH-APRIL 2019

Author

Katherine A. Rubino, Caldwell Intellectual Property Law, Boston, MA
katie@caldwellip.com

Presentation

257th ACS National Meeting – Orlando
Monday, April 1, 2019, 10:45am-11:15am
Orange County Convention Center Room W308D
”Strategies for monetization of patent portfolios in chemical fields”

Abstract

More than 3 million patent applications were filed in 2016, an 8.3% increase from 2015. As the number of patents filed worldwide continues to increase, creating a value driven patent portfolio is of utmost importance to maintain a position in the marketplace. Discussed in this presentation will be tips and strategies for monetization of biotech, pharma and life science patents. We will also examine approaches to develop a robust patent portfolio that can be treated as an asset class in and of itself.